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http://www.biomedcentral.com/1471-2407/12/360RESEARCH ARTICLE Open AccessInterstitial magnetic resonance lymphography is
an effective diagnostic tool for the detection of
lymph node metastases in patients with cervical
cancer
Ying Hong1,2,3*, Luojun Xiang3, Yali Hu1,2,3, Zhengyang Zhou2, Haiping Yu2 and Bing Zhu2Abstract
Background: The aim of the present study was to determine the feasibility of detecting sentinel lymph node (SLN)
metastases using interstitial magnetic resonance (MR) lymphography in patients with cervical cancer. MR data were
compared to pathological results from the lymph nodes excised during surgery.
Methods: Twenty-eight patients with cervical cancer were enrolled and studied from January 2006 to December
2010. All patients underwent interstitial MR lymphography to determine the presence of sentinel lymph nodes and
visualize lymphatic vessel drainage in the pelvis. Radical hysterectomy and excision of pelvic lymph nodes was
performed according to their lesion grade. Gadodiamide was injected either intradermally into the bipedal toe web,
into the labia majora or into the cervical tissue. MR results were compared with pathological reports.
Results: In 28 patients, lymphatic vessel drainage and lymph node groups were clearly visualized. Of these, 5 were
MR lymphography positive and 23 were MR lymphography negative. Six had pathologically proven metastasis, five
had true positives and 1 had a false negative in the obturator lymph node.
Conclusions: Interstitial MR lymphography can be used to determine the extent and shape of pelvic lymphatic
vessel drainage and lymph node metastases in patients with cervical cancer.
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The incidence of cervical cancer has increased signifi-
cantly, particularly in younger women [1,2]. However,
the treatment for cervical cancer, along with the preser-
vation of the patients’ organs and physiological function
as much as possible, remains a clinical challenge.
Traditional lymphography technology used during sur-
gery cannot predict lymph node metastasis of cervical
cancer before the operation. Interstitial lymphography
avoids trauma to the lymphatic system experienced in dir-
ect lymphography and can display lymph channels and* Correspondence: hongyingwjm@sina.com
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reproduction in any medium, provided the orlymph nodes [3]. Using albumin-Gd-DTA as a contrast
agent, they were able to classify regions of interest as
‘pooling’ if the macromolecular contrast media concentra-
tion increased over time, or ‘draining’ if it decreased rela-
tive to early phase images. The more invasive tumor line
had a significantly higher number of draining voxels by
MRI. Thus, lymphatic drainage patterns correlate with the
rate of metastasis and lymphangiogenesis. Drainage may
be dependent on both the invasiveness of the tumor and
on the extracellular matrix integrity, which, if reduced,
can facilitate the passage of tumor cells along with extra-
cellular fluid.
The purpose of the present study was to evaluate the
diagnostic role of interstitial MR lymphography for the de-
tection of lymph node metastases, which in combination
with the patients’ other clinical characteristics (e.g. tumor
size) will help to better define a treatment strategy.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Twenty-eight patients with cervical cancer who had
undergone uterine surgery between January 2006 and
December 2010 were included in this study. The
patients were between 35 and 76 years old. The cer-
vical tumor types included 26 squamous cell carcin-
omas and two adenosquamous carcinomas. The study
was based on the statement of ethical principles in
the Declaration of Helsinki. Accordingly, the study
was reviewed and approved by the clinical research
ethics committee of the Affiliated Drum Tower Hos-
pital of Nanjing University Medical School (Approval
Number 2010028) and signed consent was obtained
from each patient.
All patients were scanned using interstitial MR lym-
phography to examine lymphatic vessel drainage and
lymph nodes prior to pelvic surgery. Surgery included
radical hysterectomy and removal of pelvic lymph nodes
according to their lesion grade. Pathological diagnoses
were based on the analysis of the excised lymphatic
tissue.
Inclusion criteria for this study were as follows:
(1) cervical cancer, stage Ia2-IIa;
(2) no prior pelvic surgery;
(3) no birth control ring;
(4) signed consent for MR lymphography.
Patients with contraindications to MR imaging and
patients with contrast agent allergies were excluded.
The patients were admitted eight hours prior to the
exam, and received a clysma two hours before MR
lymphography. Initially, Gadodiamide was injected
intradermally into the bipedal toe web (four cases) to
evaluate image quality before the study was continued
using different injection locations. Subsequently, Gado-
diamide was injected into the labium majus in two
cases and into the cervical tissue in 22 cases to evalu-
ate the sentinel lymph node (SLN) of cervical tissue
and lymph node metastases. Patients were injected
with 12–20 ml of Gadodiamide (body weight adjusted
dose) plus 4 ml Lidocaine (2%) within 5 minutes.
Gadodiamide was injected with a 0.20-0.25 ml/kg body
weight (60 kg - 80 kg) adjusted dose leading to
injected contrast agent volumes of 12–20 ml. The tis-
sue close to the injection site was then massaged for
about 30 seconds. After contrast injection, Mupirocin
ointment (main components: Mupirocin, ointment
matrix polyethylene glycol) was applied to the injection
location to prevent infection.
MR imaging was performed immediately following ad-
ministration of Gadodiamide. The MR exams were per-
formed in the supine position on a Philips Intera 1.5 T
MR system and a Philips Achieva 3.0 T TX MR systemwith a quadrature body coil. The following MRI sequences
were used for MR lymphography of the pelvis:
1. T2-weighted(T2W)turbo spin-echo (TSE) in the axial
(ax, TRA) plane;
2. T1W_TSE_ax, T2W_SPAIR coronal (COR);
3. T2W_ SPAIR sagittal (SAG);
4. PDW_ SPAIR TRA, DWIBS TRA.
Repetition Time (TR) and Echo Time (TE) were 5.6 ms
and 1.86 ms, respectively. Each of the sequences included
a slice thickness of 0.5 mm and 300 slices. Gadodiamide
was injected into each patient within 5 minutes. Subse-
quently, a 3D MR lymphography sequence in the renal
plane was begun after 3, 6, 9, 12, 15, and 20 minutes. In
cases where the contrast injection was incomplete, the
scan was repeated until completion. The MR lymphogra-
phy sequence had a slice thickness of 0.5 mm and 300
slices with a TR=5.6 ms and TE= 1.86 ms. Subsequently,




The following diagnostic classifications were used in
the analyses of the MR images: Lymphatic metastases:
1. Positive when lymphatic vessels were discontinuous
in shape or were lymph nodes with filling defect;
2. Negative when lymphatic vessels and lymph nodes
were regular in shape.
Patients with cervical cancer of stages Ia2, Ib or IIa
were analyzed for lesion location and the extent of
lymph node involvement using interstitial MR imaging
and had radical abdominal hysterectomy and pelvic
lymph node dissection following interstitial MR imaging.
The pathological results were compared to the results of
lymphatic MR imaging.
Results
Twenty-eight patients with cervical cancer who had
undergone uterine surgery between January 2006 and
December 2010 were included in this study. Of the 28
cervical cancer patients who were scanned with MR
lymphography, there were 5 MR lymphography positive
and 23 MR lymphography negative. One case with an
MR positive result in the deep inguinal lymph node was
diagnosed by the pathologist as an internal iliac lymph
node metastasis. Six were pathologically proven to be
metastasis, five were true positives and 1 was a false
negative. The false-negative case was found to have a left
obturator lymph node metastasis.
Figure 1 1–1: MR lymphography (sagittal view) Case 1: A 54-year-old cervical cancer patient. The MRI scan of the pelvic lymphatic system
before lymphography showed no obvious lymph node metastases. The lymphography lateral map shows an irregular shape of the obturator
lymph nodes (Ob. L.N.), and the iliac blood vessel lymph nodes (I.B. L.N.) show filling defects. The lymphatic shape was not continuous. MR
lymphography in this patient was acquired using a slow subcutaneous injection of 15 ml Gadodiamide and 4 ml 2% lidocaine in the labia majora
pudendi followed by a 30 second massage of the injection site. MRI shows the lymph nodes (L.N.) and lymphatic vessels (L.Tube). 1–2:
Lymphography (coronal view) Case 1. The contrast with lymphatic (coronal view) irregular shape of the bilateral iliac blood lymph nodes (I.B.L.N.)
and the right obturator lymph nodes (Ob.L.N.). A filling defect and the absence of the left inguinal lymph nodes is shown.
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cervical injections in MR lymphography were 20.75 ml
and 13.25 ml, respectively. The homogeneity of variance
test F-value and significance (Sig.) value was 0.0 and 1.0,
respectively. The average contrast agent doses of the bi-
pedal and cervical injections were not significantly dif-
ferent according to gender. A t-test for Equality of
Means of the bipedal and cervical images is shown as a
t-value (4.361 and 4.361), degrees of freedom (6.000 and
5.981), Sig. (2-tailed) (0.005), Mean Difference (7.500),
Std. Error Difference (1.720) and 95%. Confidence inter-
vals of the Difference Lower (3.291 and 3.288) and
Upper (11.709 and 11.712) are presented.
The average clearest image time (minutes) of the bipedal
and cervical acquisitions in MR lymphography was 29.5Figure 2 Pelvic plain scan (axial view) Case 2: MR lymphography of a
view) Case 2: Coronal MR scans in patients with left obturator lymph node
portion of the right lymph node imaging. Continuous shaped lymphatic ve
specimen of the sentinel lymph node (SLN) (right obturator lymph nodes)
lymph node (R.O.L.N.) specimens of pathological anatomy (guided by visua
nodes) depending on the pathological anatomy of post-mortem specimen
lymphography.and 9.0, respectively. The homogeneity of variance test
F-value and Sig. value was 13.500 and 0.01, respectively.
The average clearest image time of the bipedal and cer-
vical acquisitions was significantly different according to
gender. A t-test for Equality of Means of the bipedal and
cervical data is shown: t-value (16.292 and 16.292),
degrees of freedom (6.000 and 3.696), Sig.(2-tailed)(0.000),
Mean Difference (20.500), Standard Error Difference
(1.256) and 95% Confidence interval of the Difference
Lower (17.421 and 16.890) and Upper (23.579 and 24.110)
is presented.
In our study, the accuracy of interstitial MR lympho-
graphy for detecting lymph node metastases was 92.9%.
The sensitivity and specificity were 80% (4/5) and 95.7%
(22/23), respectively.47-year-old patient with cervical cancer. Lymphography (coronal
s are clearly visible, the left side of the developing lyphatic clear
ssels and no abnormal lymph nodes were observed. Surgical
(guided by visual blue dye lymphography) Left: SLN (right obturator
l blue dye lymphography (V.B.D.L.)). Right: SLN (right obturator lymph
s can be seen in the lymph nodes guided by visual blue dye
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complications or allergic reactions were observed. In the
four patients who had bipedal MR lymphography five
minutes after the injection of Gadodiamide, the lympha-
tics and lymph nodes were clearly visible. The image
that best displayed the lymph nodes was acquired after
30 minutes. When scanning was extended beyond
45 minutes, image quality decreased and the MR con-
trast agent was mostly visible in the bladder. In two
patients with interstitial MR lymphography, the best
image quality in MR lymphography was observed after
17 minutes post-injection (see Case 1, Figure 1). The
image quality decreased in these cases after 30 minutes
when most of the contrast agent was found in theFigure 3 Lymphography (lateral position) Case3:A 42-year-old cervical cancer patient received a slow injection of 20 ml Gadodiamide
and 6 ml 2% lidocaine over three minutes. The injection was followed by a 20-minute massage within the MRI system. MR lymphography
displays the lymph nodes (L.N.) and lymphatic vessels (L.T.) at various time points. After 12 minutes, the contrast agents appeared mainly in the
bladder. There are unmarked elliptically shaped lymph nodes of the iliac blood vessel. The lymphography lateral map was clear. There are
numerous unmarked areas with similar shapes to the linear lymph vessels.The lymphatic shape was continuous.bladder (see Case 3, Figure 2). In 22 patients with injec-
tion of the contrast agent into the cervical tissue, the
best image quality occurred nine minutes post-injection
(see Case 2 and Case 4, Figures 3 and 4). Cervix lympho-
graphy was able to display most cervical lymph node
metastases. Interstitial MR lymphography is shown for
SLN where Gadodiamide was injected into the cervical
tissue in 22 cases (Table 1).
In 22 cases, SLN were observed in operations guided
by blue dye lymphography where visual blue dye was
injected into the cervical tissue. Tracer of blue dye tra-
vels along the same lymphatic drainage pathway as cer-
vical cancer cells to reach the first station lymph nodes.
In surgery, SLN can be identified according to the
stained lymph nodes, and can help to guide the biopsy.
The blue dye tracer method helped to identify 40 SLN in
22 patients. In our study, intraoperative blue dye lym-
phography showed an SLN average of 1.8 per patient
(40/22) (see Table 1).Preoperative MRI and intraoperative blue dye lympho-
graphy were compared: MRI lymphography showed an
accuracy rate of 85% for the detection of SLN (56/66).
Tracer of blue dye lymphography showed an accuracy
rate of 61% for the detection of SLN (40/66). A signifi-
cance of p < 0.01 was calculated using a χ2-test.
Preoperative MRI and pathological anatomy were also
compared: depending on the pathological anatomy of
the specimens, 66 positive SLN could be found (guided
by preoperative MRI and visual blue dye lymphography),
on average, 3.0 lymph nodes per patient (66/22) were
observed.
DiscussionInterstitial MR lymphography in cervical cancer allows
for the detection of lymph node metastases non-inva-
sively. Interstitial MR lymphography is gradually attract-
ing more attention since it helps to overcome the
deficiencies of standard MR imaging techniques in mak-
ing qualitative diagnoses of lymph node status. MR lym-
phography is currently the only way to observe lymph
nodes and to understand their function and is of great
value in diagnosing the involvement of retroperitoneal
and pelvic lymph nodes.
Lymphatic metastasis is the primary metastasis occur-
ring in cervical cancer, which not only determines the
prognosis but also the choice of treatment and surgical
methods. At present, the various methods for detecting
lymph node metastases, such as CT, MR and PET-CT, all
have low sensitivity and specificity. Recently, lymphogra-
phy has become the primary focus in detecting lymph
node metastases. Direct lymphography involves injecting
contrast agents (such as iodized oil) subcutaneously,
Figure 4 4–1: Pelvic plain scan (axial view) Case 4: A 38-year-
old patient with cervical cancer (Ib1) was injected with
Gadodiamide into the cervical tissue. MR lymphography shows
the lymph nodes and lymphatic vessels clearly. MR lymphography in
the axial view shows the lymph nodes and lymphatic vessels. The
arrow marks the right cervical lymph nodes (R.N.), developing clear,
with no abnormal increases and no filling defects. The other arrow
displays the continuity of the right small lymphatic channels (R.T.).
4–2: Lymphography (lateral position). MR lymphography in the
coronal view shows the lymph nodes and lymphatic vessels. Two
arrows mark the left lymph nodes (L.N.), developing clear, with no
abnormal increase and no filling defects. The other arrow displays
the continuity of the left small lymphatic channels (L.T.). 4–3: Pelvis
plain scan (coronal view). MR lymphography clearly shows the
lymph nodes and lymphatic vessels. The arrow marks the left lymph
nodes (L.N.), clearly developed with no abnormal increase and no
filling defect. The other arrow displays the continuity of the left
small lymphatic channels (L.T.).
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X-ray. This technique is time-consuming and potentially
dangerous, with incidents of pulmonary embolisms
reported. Furthermore, the spatial resolution of X-ray lym-
phography is poor, limiting its use in clinical practice.
Interstitial MR lymphography with subcutaneous injection
of contrast agents (strictly controlled in the skin) allows
scanning of the pelvic lymph system. This method is agood way to visualize the pelvic lymph nodes, and has
been confirmed by recent research studies [4,5].
A prospective consecutive study for SLN identifica-
tion with preoperative SPECT/CT and planar images
(technetium-99 m colloid albumin injection around the
tumor) and posterior intraoperative detection with both
blue dye and a handheld or laparoscopic gamma probe
was reported by Díaz-Feijoo et al. A total of 35 SLN were
detected with planar images and 40 SLN were identified
and well-located by SPECT/CT lymphoscintigraphy (me-
dian 2.0 nodes per patient). In 5/22 patients (22.7%)
SPECT/CT procedure improved the number of localized
SLN. Intraoperatively, 57 SLNs were identified, with a me-
dian of 3 SLNs per patient by gamma probe (a total of 53
hot nodes) and a median of 2 nodes per patient after blue
dye injection (a total of 42 blue nodes). Microscopic nodal
metastases (eight nodes, corresponding to four patients)
were confirmed in 18 [6]. Likewise, in a study by Lécuru F
et al., intraoperative radioisotope-blue dye mapping
detected at least one SLN in 136 patients (97.8%; 95% CI,
93.8% to 99.6%), 23 of whom had true-positive results and
two who had false-negative results, yielding 92.0% sensi-
tivity (23 of 25; 95% CI, 74.0% to 99.0%) and 98.2% NPV
(111 of 113; 95% CI, 74.0% to 99.0%) for node metastasis
detection. No false-negative results were observed in the
104 patients (76.5%) in whom SLN were identified bilat-
erally [7]. In our study, the accuracy of interstitial MR
lymphography for detecting lymph node metastases was
92.9%. The sensitivity and specificity were 80% (4/5) and
95.7% (22/23), respectively. The PPD was 100%, and NPD
was 95.7%. The results before surgery non-invasively were
superior in detecting lymph node metastases compared to
the literature.
Therefore, interstitial MR lymphography in detecting
lymph node metastases is of significance for clinical de-
cision making in patients with cervical cancer. MR lym-
phography should be routinely performed prior to
Table 1 Results of interstitial MR lymphography, visual blue dye lymphography and pathological anatomy in 22 cases
case Preoperative MRI Intraoperative blue dye lymphography Pathological anatomy
position amount nature position amount position amount nature
1 B.Ob. LN 2 - B.Ob. LN 2 B.Ob. LN 3 -
2 B.Ob. LN 2 - B.Ob. LN 2 B.Ob. LN 2 -
3 L.I.I.B.LN 3 - L.I.I.B.LN 2 L.I.I.B.LN 3 -
4 B.Ob. LN 2 + B.Ob. LN 1 B.Ob. LN 2 +
5 B.E.I.B.LN. 2 - B.E.I.B.LN. 3 B.E.I.B.LN. 4 -
6 B.E.I.B.LN. 3 - B.E.I.B.LN. 2 B.E.I.B.LN. 3 -
7 R.I.I.B.LN 1 + R.I.I.B.LN 1 R.I.I.B.LN 1 +
8 B.Ob. LN 5 - B.Ob. LN 2 B.Ob. LN 4 -
9 B.Ob. LN 2 - B.Ob. LN 2 B.Ob. LN 2 -
10 R.Ob. LN 1 - R.Ob. LN 1 R.Ob. LN 1 -
11 L.Ob. LN 2 - L.Ob. LN 1 L.Ob. LN 3 -
12 L.D.I.LN. 2 - L.I.I.B.LN 1 L.I.I.B.LN 3 -
13 L.Ob. LN 1 - L.Ob. LN 1 L.Ob. LN 1 +
14 B.Ob. LN 3 - B.Ob. LN 1 B.Ob. LN 4 -
15 C.LN. 4 - C.LN. 2 C.LN. 4 -
16 L.Ob. LN 3 - L.Ob. LN 1 L.Ob. LN 3 -
17 R.Ob. LN 3 + R.Ob. LN 3 R.Ob. LN 4 +
18 L.Ob. LN 3 + L.Ob. LN 3 L.Ob. LN 3 +
19 L.Ob. LN 3 + L.Ob. LN 1 L.Ob. LN 3 +
20 B.E.I.B.LN. 2 - B.E.I.B.LN. 3 B.E.I.B.LN. 4 -
21 B.Ob. LN 3 - B.Ob. LN 2 B.Ob. LN 5 -
22 B.E.I.B.LN. 4 - B.E.I.B.LN. 3 B.E.I.B.LN. 4 -
Total 56 40 66
(−) Negative case was diagnosed as lymph node metastasis. (+)Positive case was diagnosed as lymph node metastasis.
(L.) Left, (R.)Right, (B.) Bilateral, (Ob. LN.) obturator lymph nodes, (E.I.B.LN.) external iliac blood vessel lymph nodes, (I.I.B.LN.) internal iliac blood vessel lymph
nodes, cervical lymph nodes (C.LN.), deep inguinal lymph node (D.I.LN.).
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usually missed by clinical examinations, thus making
diagnosis and staging more accurate.
Conclusion
Interstitial MR lymphography enables the visualization
of the extent and shape of pelvic lymphatic vessels and
lymph node metastases in patients with cervical cancer.
The evaluation of lymph node metastases is important
for the treatment and prognosis of cervical cancer.
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